Taylor Ben R 4

What Happened Ben R. Taylor, Chief Financial Officer of Recursion Pharmaceuticals (RXRX), had 25,018 shares disposed on May 15, 2026 to satisfy tax withholding related to a net settlement of restricted stock units (RSUs). The shares were valued at $3.04 each, totaling approximately $76,055. This was a tax-withholding/net-settlement action (not an open-market sale) and is generally considered a routine administrative transaction.

Key Details

• Transaction date: 2026-05-15; Form 4 filed: 2026-05-19 (filed timely).
• Transaction code: F — Payment of exercise price or tax liability.
• Shares withheld/disposed: 25,018 at $3.04 per share; total value ≈ $76,055.
• Shares owned after transaction: not specified in the provided filing excerpt.
• Footnote F1: Issuer withheld these shares to satisfy its tax withholding and remittance obligations in connection with the net settlement of RSUs.
• Filing timeliness: Report appears timely (filed within required period).

Context This was a withholding of shares to cover tax obligations arising from RSU settlement (a "net settlement" or cashless-coverage), not an open-market sale. Such withholdings are routine and reflect tax mechanics rather than a direct buy/sell sentiment by the insider. Purchases or open-market sales are typically more informative about an insider's market view.